Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin tyrosine ligase-like protein 11 (TTLL11) is an enzyme of the TTLL family responsible for catalyzing the polyglutamylation of microtubules, a post-translational modification that extends glutamate chains primarily on the α- and β-tubulin subunits[1][3]. TTLL11 acts preferentially as an elongase, directly increasing glutamate chain length rather than initiating lateral branching, a property that distinguishes it from other TTLL family members. Functionally, TTLL11 regulates microtubule dynamics critical for spindle assembly during mitosis and is essential for accurate chromosome segregation[3]. It also contributes to the maintenance of ciliary structure and function, with genetic variants implicated in diseases such as adolescent idiopathic scoliosis[2]. In the nervous system, TTLL11 expression influences cognitive processes, and genetic variation has been associated with attention performance[2]. Dysregulation of TTLL11 has been linked to cancer through impaired chromosome segregation and may play a role in neurodevelopmental disorders[3][2]. No drugs currently target TTLL11 directly, but the enzyme is of interest for its fundamental role in cytoskeletal regulation and disease pathology[1][2][3].
For any hypothetical drugs targeting TTLL11: - Inhibition would likely reduce polyglutamylation of microtubules, possibly impairing mitotic spindle function, chromosome segregation, and ciliary activity. - Activation or upregulation could increase microtubule polyglutamylation, impacting cell division and cytoskeleton integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin tyrosine ligase-like protein 11 (TTLL11).